BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7405836)

  • 21. Synergistic effect of nifedipine and propranolol on adenosine (catabolite) release from ischemic rat heart.
    Harmsen E; De Tombe PP; De Jong JW
    Eur J Pharmacol; 1983 Jun; 90(4):401-9. PubMed ID: 6884429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisolone.
    Nayler WG; Fassold E; Yepez C
    Cardiovasc Res; 1978 Mar; 12(3):152-61. PubMed ID: 647719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium channel blocking agents.
    Ewy GA
    Med Times; 1981 Aug; 109(8):36-8. PubMed ID: 6268924
    [No Abstract]   [Full Text] [Related]  

  • 24. Beneficial enhancement of coronary blood flow by nifedipine. Comparison with nitroglycerin and beta blocking agents.
    Engel HJ; Lichtlen PR
    Am J Med; 1981 Oct; 71(4):658-66. PubMed ID: 6792917
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of various antianginal agents on the frequency and duration of myocardial ischemic episodes in patients with stable angina pectoris].
    Voronkov LG; Lysenko AF
    Kardiologiia; 1992; 32(11-12):67-70. PubMed ID: 1297887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardioprotective effects of verapamil on mitochondrial function in the ischemic myocardium].
    Kucharská J; Gvozdjáková A; Gvozdják J
    Cesk Fysiol; 1988; 37(6):545-8. PubMed ID: 3242858
    [No Abstract]   [Full Text] [Related]  

  • 27. Protective effects of calcium antagonists on energy and substrate metabolism during ischemia and reperfusion in hypertensive myocardial hypertrophy.
    Buser PT; Wagner S; Wu S; Higgins CB; Wikman-Coffelt J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S87-92. PubMed ID: 1725012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review.
    Mitchell LB; Schroeder JS; Mason JW
    Am J Cardiol; 1982 Feb; 49(3):629-35. PubMed ID: 6277182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal mitochondrial oxidative phosphorylation of ischemic myocardium reversed by Ca2+-chelating agents.
    Peng CF; Kane JJ; Murphy ML; Straub KD
    J Mol Cell Cardiol; 1977 Nov; 9(11):897-908. PubMed ID: 412978
    [No Abstract]   [Full Text] [Related]  

  • 30. [In vitro effect of verapamil on the function of isolated mitochondria of the rabbit heart perfused under conditions of aerobiosis, ischemia and reperfusion].
    Ferrari R; Di Lisa F; Cucchini F; Lanti MP; Raddino R
    Cardiologia; 1982; 27(4):351-6. PubMed ID: 6927481
    [No Abstract]   [Full Text] [Related]  

  • 31. Blood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranolol.
    Harris L; Dargie HJ; Lynch PG; Bulpitt CJ; Krikler DM
    Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1148-51. PubMed ID: 6803871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non-invasive evaluation of the action of nifedipine on left ventricular function in subjects with ischemic cardiopathy].
    De Caprio L; Romano M; Violini R; Bellotti P; Cuomo S; Carlomagno A; Bonaduce D; Rengo F
    Boll Soc Ital Cardiol; 1978; 23(10):1727-33. PubMed ID: 261836
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative pharmacodynamics study of korinfar and isoptin in ischemic heart disease].
    Savvateev KL; Shinbaeva NA; Vygodin VA; Nikolenko SA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):64-70. PubMed ID: 7259869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged protective effect of propranolol on hypoxic heart muscle.
    Nayler WG; Yepez CE; Fassold E; Ferrari R
    Am J Cardiol; 1978 Aug; 42(2):217-25. PubMed ID: 685835
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism(s) of calcium antagonists and ischemia.
    Hugenholtz PG; de Jong JW
    Z Kardiol; 1984; 73 Suppl 2():89-93. PubMed ID: 6528706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of canine cardiac mitochondrial function by verapamil-cardioplegia during ischemic arrest.
    Yoon SB; McMillin-Wood JB; Michael LH; Lewis RM; Entman ML
    Circ Res; 1985 May; 56(5):704-8. PubMed ID: 3995698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nifedipine--a new calcium antagonist in experimental myocardial necrosis.
    Ganguly PK; Srivastava LM; Bora PS; Gupta MP; Seth SD
    Indian J Med Res; 1981 Apr; 73():617-24. PubMed ID: 7262935
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of verapamil and nifedipine on ischemic myocardial metabolism in dogs.
    Ichihara K; Ichihara M; Abiko Y
    Arzneimittelforschung; 1979; 29(10):1539-44. PubMed ID: 583218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris.
    de Ponti C; Mauri F; Ciliberto GR; Carù B
    Eur J Cardiol; 1979 Jul; 10(1):47-58. PubMed ID: 467482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of nifedipine in myocardial ischemia assessed by phosphorus-31 nuclear magnetic resonance.
    Ruigrok TJ; van Echteld CJ; de Kruijff B; Borst C; Meijler FL
    Eur Heart J; 1983 May; 4 Suppl C():109-13. PubMed ID: 6617693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.